What do women want during medical abortion?
A questionnaire study was carried out to investigate the needs of women undergoing a medical abortion induced by mifepristone in combination with either gemeprost pessaries or oral misoprostol. One-hundred-and-eighty women undergoing medical abortion of pregnancy of up to 63 days amenorrhoea were ra...
Gespeichert in:
| Veröffentlicht in: | Contraception (Stoneham) 1992-11, Vol.46 (5), p.435-442 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 442 |
|---|---|
| container_issue | 5 |
| container_start_page | 435 |
| container_title | Contraception (Stoneham) |
| container_volume | 46 |
| creator | Thong, K Joo Dewar, Maria H Baird, David T |
| description | A questionnaire study was carried out to investigate the needs of women undergoing a medical abortion induced by mifepristone in combination with either gemeprost pessaries or oral misoprostol. One-hundred-and-eighty women undergoing medical abortion of pregnancy of up to 63 days amenorrhoea were randomised to treatment in the sitting-room (treatment room) or in the ward. Overall, 77% and 69% treated in the sitting-room and ward, respectively, would have preferred treatment in the sitting-room. Fifty-four per cent did not wish their partner or friend to be present and 76% would prefer to stay in hospital following administration of prostaglandin. Ninety-five per cent of the patients would recommend this method of abortion to their friends. Women who received misoprostol required significantly less analgesia than women who were given 1 mg gemeprost as a vaginal pessary. The requirement for opiate analgesia was not influenced by parity, gestation of pregnancy, history of dysmenorrhoea or the dose of mifepristone. Almost 100% of the patients were satisfied with this method of treatment. This study indicates that the majority of women undergoing medical abortion prefer to be treated in a group, a method which is highly cost-effective. |
| doi_str_mv | 10.1016/0010-7824(92)90147-L |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73331140</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>001078249290147L</els_id><sourcerecordid>73331140</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-44c3f0afeceba962cd38504c30f824ec69ba0457260801a001a8efc39f24d98d3</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMo67r6DxR6EFGkOmnSJrkosvgFBS-Kx5CmqUb6sSati__erF3Wm6chM88Mbx6EDjFcYMDZJQCGmPGEnorkTACmLM630BRzJmJIMd9G0w2yi_a8_wAAJlI2QRNMU84FTNH567vqo7KLll1j2mip2vAanG3fosaUVqs6UkXnetu11_top1K1NwfrOkMvd7fP84c4f7p_nN_ksSY862NKNalAVUabQoks0SXhKYQmVCGJ0ZkoFNCUJRlwwCpkVNxUmogqoaXgJZmhk_HuwnWfg_G9bKzXpq5Va7rBS0YIwZhCAOkIatd570wlF842yn1LDHLlSK4EyJUAKRL560jmYe1ofX8owif_lkYpYX68nisfBFROtdr6DUYpyUTGAnY1Yia4-LLGSa-taXXQ5ozuZdnZ_3P8AITZgNY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73331140</pqid></control><display><type>article</type><title>What do women want during medical abortion?</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Thong, K Joo ; Dewar, Maria H ; Baird, David T</creator><creatorcontrib>Thong, K Joo ; Dewar, Maria H ; Baird, David T</creatorcontrib><description>A questionnaire study was carried out to investigate the needs of women undergoing a medical abortion induced by mifepristone in combination with either gemeprost pessaries or oral misoprostol. One-hundred-and-eighty women undergoing medical abortion of pregnancy of up to 63 days amenorrhoea were randomised to treatment in the sitting-room (treatment room) or in the ward. Overall, 77% and 69% treated in the sitting-room and ward, respectively, would have preferred treatment in the sitting-room. Fifty-four per cent did not wish their partner or friend to be present and 76% would prefer to stay in hospital following administration of prostaglandin. Ninety-five per cent of the patients would recommend this method of abortion to their friends. Women who received misoprostol required significantly less analgesia than women who were given 1 mg gemeprost as a vaginal pessary. The requirement for opiate analgesia was not influenced by parity, gestation of pregnancy, history of dysmenorrhoea or the dose of mifepristone. Almost 100% of the patients were satisfied with this method of treatment. This study indicates that the majority of women undergoing medical abortion prefer to be treated in a group, a method which is highly cost-effective.</description><identifier>ISSN: 0010-7824</identifier><identifier>EISSN: 1879-0518</identifier><identifier>DOI: 10.1016/0010-7824(92)90147-L</identifier><identifier>PMID: 1458890</identifier><identifier>CODEN: CCPTAY</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Abortifacient Agents, Nonsteroidal ; Abortion, Induced - psychology ; Acetaminophen - therapeutic use ; Administration, Oral ; Adolescent ; Adult ; Alprostadil - analogs & derivatives ; Bias ; Biological and medical sciences ; Birth control ; Codeine - analogs & derivatives ; Codeine - therapeutic use ; Female ; Gynecology. Andrology. Obstetrics ; Heroin - therapeutic use ; Humans ; Induced abortion. Therapeutic abortion ; Medical sciences ; Mifepristone ; Misoprostol ; Pain - drug therapy ; Patient Satisfaction ; Pessaries ; Population ; Pregnancy</subject><ispartof>Contraception (Stoneham), 1992-11, Vol.46 (5), p.435-442</ispartof><rights>1992</rights><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-44c3f0afeceba962cd38504c30f824ec69ba0457260801a001a8efc39f24d98d3</citedby><cites>FETCH-LOGICAL-c386t-44c3f0afeceba962cd38504c30f824ec69ba0457260801a001a8efc39f24d98d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0010-7824(92)90147-L$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4436967$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1458890$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thong, K Joo</creatorcontrib><creatorcontrib>Dewar, Maria H</creatorcontrib><creatorcontrib>Baird, David T</creatorcontrib><title>What do women want during medical abortion?</title><title>Contraception (Stoneham)</title><addtitle>Contraception</addtitle><description>A questionnaire study was carried out to investigate the needs of women undergoing a medical abortion induced by mifepristone in combination with either gemeprost pessaries or oral misoprostol. One-hundred-and-eighty women undergoing medical abortion of pregnancy of up to 63 days amenorrhoea were randomised to treatment in the sitting-room (treatment room) or in the ward. Overall, 77% and 69% treated in the sitting-room and ward, respectively, would have preferred treatment in the sitting-room. Fifty-four per cent did not wish their partner or friend to be present and 76% would prefer to stay in hospital following administration of prostaglandin. Ninety-five per cent of the patients would recommend this method of abortion to their friends. Women who received misoprostol required significantly less analgesia than women who were given 1 mg gemeprost as a vaginal pessary. The requirement for opiate analgesia was not influenced by parity, gestation of pregnancy, history of dysmenorrhoea or the dose of mifepristone. Almost 100% of the patients were satisfied with this method of treatment. This study indicates that the majority of women undergoing medical abortion prefer to be treated in a group, a method which is highly cost-effective.</description><subject>Abortifacient Agents, Nonsteroidal</subject><subject>Abortion, Induced - psychology</subject><subject>Acetaminophen - therapeutic use</subject><subject>Administration, Oral</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Alprostadil - analogs & derivatives</subject><subject>Bias</subject><subject>Biological and medical sciences</subject><subject>Birth control</subject><subject>Codeine - analogs & derivatives</subject><subject>Codeine - therapeutic use</subject><subject>Female</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Heroin - therapeutic use</subject><subject>Humans</subject><subject>Induced abortion. Therapeutic abortion</subject><subject>Medical sciences</subject><subject>Mifepristone</subject><subject>Misoprostol</subject><subject>Pain - drug therapy</subject><subject>Patient Satisfaction</subject><subject>Pessaries</subject><subject>Population</subject><subject>Pregnancy</subject><issn>0010-7824</issn><issn>1879-0518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LxDAQhoMo67r6DxR6EFGkOmnSJrkosvgFBS-Kx5CmqUb6sSati__erF3Wm6chM88Mbx6EDjFcYMDZJQCGmPGEnorkTACmLM630BRzJmJIMd9G0w2yi_a8_wAAJlI2QRNMU84FTNH567vqo7KLll1j2mip2vAanG3fosaUVqs6UkXnetu11_top1K1NwfrOkMvd7fP84c4f7p_nN_ksSY862NKNalAVUabQoks0SXhKYQmVCGJ0ZkoFNCUJRlwwCpkVNxUmogqoaXgJZmhk_HuwnWfg_G9bKzXpq5Va7rBS0YIwZhCAOkIatd570wlF842yn1LDHLlSK4EyJUAKRL560jmYe1ofX8owif_lkYpYX68nisfBFROtdr6DUYpyUTGAnY1Yia4-LLGSa-taXXQ5ozuZdnZ_3P8AITZgNY</recordid><startdate>19921101</startdate><enddate>19921101</enddate><creator>Thong, K Joo</creator><creator>Dewar, Maria H</creator><creator>Baird, David T</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19921101</creationdate><title>What do women want during medical abortion?</title><author>Thong, K Joo ; Dewar, Maria H ; Baird, David T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-44c3f0afeceba962cd38504c30f824ec69ba0457260801a001a8efc39f24d98d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Abortifacient Agents, Nonsteroidal</topic><topic>Abortion, Induced - psychology</topic><topic>Acetaminophen - therapeutic use</topic><topic>Administration, Oral</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Alprostadil - analogs & derivatives</topic><topic>Bias</topic><topic>Biological and medical sciences</topic><topic>Birth control</topic><topic>Codeine - analogs & derivatives</topic><topic>Codeine - therapeutic use</topic><topic>Female</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Heroin - therapeutic use</topic><topic>Humans</topic><topic>Induced abortion. Therapeutic abortion</topic><topic>Medical sciences</topic><topic>Mifepristone</topic><topic>Misoprostol</topic><topic>Pain - drug therapy</topic><topic>Patient Satisfaction</topic><topic>Pessaries</topic><topic>Population</topic><topic>Pregnancy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thong, K Joo</creatorcontrib><creatorcontrib>Dewar, Maria H</creatorcontrib><creatorcontrib>Baird, David T</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Contraception (Stoneham)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thong, K Joo</au><au>Dewar, Maria H</au><au>Baird, David T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>What do women want during medical abortion?</atitle><jtitle>Contraception (Stoneham)</jtitle><addtitle>Contraception</addtitle><date>1992-11-01</date><risdate>1992</risdate><volume>46</volume><issue>5</issue><spage>435</spage><epage>442</epage><pages>435-442</pages><issn>0010-7824</issn><eissn>1879-0518</eissn><coden>CCPTAY</coden><abstract>A questionnaire study was carried out to investigate the needs of women undergoing a medical abortion induced by mifepristone in combination with either gemeprost pessaries or oral misoprostol. One-hundred-and-eighty women undergoing medical abortion of pregnancy of up to 63 days amenorrhoea were randomised to treatment in the sitting-room (treatment room) or in the ward. Overall, 77% and 69% treated in the sitting-room and ward, respectively, would have preferred treatment in the sitting-room. Fifty-four per cent did not wish their partner or friend to be present and 76% would prefer to stay in hospital following administration of prostaglandin. Ninety-five per cent of the patients would recommend this method of abortion to their friends. Women who received misoprostol required significantly less analgesia than women who were given 1 mg gemeprost as a vaginal pessary. The requirement for opiate analgesia was not influenced by parity, gestation of pregnancy, history of dysmenorrhoea or the dose of mifepristone. Almost 100% of the patients were satisfied with this method of treatment. This study indicates that the majority of women undergoing medical abortion prefer to be treated in a group, a method which is highly cost-effective.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>1458890</pmid><doi>10.1016/0010-7824(92)90147-L</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0010-7824 |
| ispartof | Contraception (Stoneham), 1992-11, Vol.46 (5), p.435-442 |
| issn | 0010-7824 1879-0518 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_73331140 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
| subjects | Abortifacient Agents, Nonsteroidal Abortion, Induced - psychology Acetaminophen - therapeutic use Administration, Oral Adolescent Adult Alprostadil - analogs & derivatives Bias Biological and medical sciences Birth control Codeine - analogs & derivatives Codeine - therapeutic use Female Gynecology. Andrology. Obstetrics Heroin - therapeutic use Humans Induced abortion. Therapeutic abortion Medical sciences Mifepristone Misoprostol Pain - drug therapy Patient Satisfaction Pessaries Population Pregnancy |
| title | What do women want during medical abortion? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T19%3A03%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=What%20do%20women%20want%20during%20medical%20abortion?&rft.jtitle=Contraception%20(Stoneham)&rft.au=Thong,%20K%20Joo&rft.date=1992-11-01&rft.volume=46&rft.issue=5&rft.spage=435&rft.epage=442&rft.pages=435-442&rft.issn=0010-7824&rft.eissn=1879-0518&rft.coden=CCPTAY&rft_id=info:doi/10.1016/0010-7824(92)90147-L&rft_dat=%3Cproquest_cross%3E73331140%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73331140&rft_id=info:pmid/1458890&rft_els_id=001078249290147L&rfr_iscdi=true |